The Emergency Contraceptive Pills Market To Stage Innovative Parameters For Growth From 2022

The Emergency Contraceptive Pills Market is bound to reach US$ 1.2 Billion at a CAGR of 3% between 2022. The modern-day situation says that the healthcare sector is witnessing an optimization and reposition of the business models to obtain enhanced patient outcomes. With real-time analytics known to improve patient care and the fact that consumers are shifting towards the preventive model of care, the healthcare vertical is likely to witness greater strides in the forecast period.

Strategizing The Moves For The Next Decade? See Through Sample Of Emergency Contraceptive Pills Market Report! https://www.persistencemarketresearch.co/samples/18343

Negative perceptions about emergency contraception are likely to hamper the sales of “morning after” pills in the future. Despite the high accessibility of emergency contraceptive pills, followed by rising awareness of highly-effective birth control methods, incidences of unwanted or mistimed pregnancies persist.

Moreover, high risk of morbidity and mortality associated with these pregnancies is disintegrating the fabric of urban cultures.

Company Profile

Teva Pharmaceutical Industries Ltd.
Bayer AG, HRA Pharma
Piramal Enterprises Limited
Mankind Pharma Ltd.
Richter Gedeon Nyrt
Lupin Limited
Cooper Pharma
Pfizer Inc.
Zhejiang Xianju Pharmaceutical Co.
Others

While unprotected sex continues to be a matter of mutual consent, obstetricians advise couples to opt for emergency contraception, particularly in healthcare settings with lack of accessibility to proper & safe abortion. Since unprotected sex also increases the risks of sexually transmitted infections, the ineffectiveness of emergency contraceptive pills in protection from venereal diseases continues to be a concern for manufacturers.

Sales of emergency contraceptive pills are also being adversely impacted by unresolved side effects of emergency contraception – which include time constraint for intake, heavy vomiting, muscle spasms, and feeling nauseous.

According to Persistence Market Research’s newly-published study, the global sales of emergency contraceptive pills are expected to dwindle in the next five years. By the end of 2022, the global market for emergency contraceptive pills will have reached a value of just over US$ 1,230 Mn. During the forecast period, 2017-2022, the global emergency contraceptive pill market is anticipated to exhibit sluggish growth and reflect less than 3% CAGR.

Starting With The New Decade On A Diligent Note In The Emergency Contraceptive Pills Market? https://www.persistencemarketresearch.co/methodology/18343

Combination Pills showcase promising growth potential

The report segments the global market for emergency contraceptive pills on the basis of products, among which combination pills are expected to dominate the market revenues.

In the foreseeable future, combination pills will witness relatively higher sales in the global market, primarily due to their health benefits in reducing risk of ectopic pregnancy. In 2017, nearly two-fifth of revenues procured in the global emergency contraceptive pills market will be contributed by global sales of combination pills.

On the contrary, use of estrogen pills for emergency contraception will lose traction. Over the forecast period, estrogen pills as a product in the global emergency contraceptive pills market will exhibit revenue growth at just 1.5% CAGR.

Demand for progesterone pills is also expected to drop, particularly owing to their side effects which include joint pain, hot flashes, and diarrhea.

How About Obtaining Insights About The Region To Enter Concerning The Emergency Contraceptive Pills Market? Press The “Purchase Now” Button To Have Our Emergency Contraceptive Pills Market Report! https://www.persistencemarketresearch.com/checkout/18343

Online Traders will reflect low sales growth

Key findings from the report indicate drug stores and hospital pharmacies as the two largest sales channels for emergency contraceptive pills. In 2017, sales of emergency contraceptive pills through these channels is expected to account for collective global revenue share of nearly 70%.

Online sales of emergency contraceptive pills will incur a considerable decline, and procure not more than US$ 160 Mn in global revenues by the end of 2022.

The report also identifies North America as the largest market for emergency contraceptive pills. The International Consortium for Emergency Contraception is based in the US and serves the mission of expanding access to safe and appropriate use of emergency contraception products.

'PMR' Exclusive Reports-

In Vitro Protein Expression Market: https://www.persistencemarketresearch.com/market-research/in-vitro-protein-expression-market.asp

Cancer Supportive Care Products Market: https://www.persistencemarketresearch.com/market-research/cancer-supportive-care-products-market.asp

Medical Case Management Services Market: https://www.persistencemarketresearch.com/market-research/medical-case-management-services-market.asp

Osteoarthritis Market: https://www.persistencemarketresearch.com/market-research/osteoarthritis-market.asp

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.